We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Dual-Energy CT Appears Promising for Evaluating the Severity of Gout

By MedImaging International staff writers
Posted on 19 May 2011
The incidence of gout is on the rise and duel-energy computed tomography (CT) imaging has the potential to allow noninvasive diagnosis of the disease, according to Canadian radiologists.

Gout is caused by the deposition of monosodium urate (MSU) monohydrate crystals that stimulate acute episodes of inflammation. Chronic tophaceous gout often presents as juxtarticular soft-tissue masses, distinct erosions, overhanging bony margins, and thickening of the synovium. Gout affects more than six million people in the United States alone and "a noninvasive means of diagnosing gout would be highly desirable," said Khalid Khashoggi, MD, from the University of British Columbia (Vancouver, BC, Canada), and Vancouver General Hospital, and one of the authors of the study.

"Dual-energy CT can detect monosodium urate in different tissues in the body, which will have a huge impact on the understanding of gout and will help in detecting subclinical cases and will allow monitoring response to treatment," said Dr. Khashoggi. "The technology will also help in problem solving in atypical cases of gout," he said.

The study's findings were presented in conjunction with the 2011 American Roentgen Ray Society's (ARRS) annual meeting in May 2011, held in Chicago (IL, USA).

Related Links:

University of British Columbia


Half Apron
Demi
Digital X-Ray Detector Panel
Acuity G4
Biopsy Software
Affirm® Contrast
Pocket Fetal Doppler
CONTEC10C/CL

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.